top of page
2covidRolledMagazine copy.jpg

Sofia 2 Sars-Cov-2AD CAMPAIGN

Testing during a pandemic.

Tracking the virus is as important as testing for it.

Strategy

Design

​

sarsBothAds.jpg

Quidel Corporation was granted Emergency Use Authorization (EUA) for its Sofia SARS Antigen Fluorescent Immunoassay (FIA). The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.

Brook-Schwartz+ suggested a series of ads focusing on testing for Covid-19, not only for Covid-19 testing, but the devices ability for wireless surveillance testing and reporting.

in 2020 Quidel Corporation witnessed a 211% increase in sales associated with Covid-19

We can do this for you.

bottom of page